{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T03:15:49Z","timestamp":1783221349848,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.clgc.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T10:56:06Z","timestamp":1586861766000},"page":"e684-e687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Negative Biopsy Histology in Men With PI-RADS Score 5 in Daily Clinical Practice: Incidence of Granulomatous Prostatitis"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8375-4419","authenticated-orcid":false,"given":"Pietro","family":"Pepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pennisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2020.04.001_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/bju.13711","article-title":"Multicentre evaluation of target and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy","volume":"120","author":"Hansen","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2020.04.001_bib2","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1111\/bju.12670","article-title":"Multiparametric magnetic resonance imaging (MRI) and subsequent MRI\/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers","volume":"114","author":"Volkin","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2020.04.001_bib3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00345-015-1749-3","article-title":"Can MRI\/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?","volume":"34","author":"Pepe","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib4","first-page":"1613","article-title":"Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR","volume":"196","author":"Rosenkrantz","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/cncr.29874","article-title":"Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies","volume":"122","author":"Filson","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2020.04.001_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.purol.2017.10.001","article-title":"Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?","volume":"28","author":"Albisinni","year":"2018","journal-title":"Prog Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib7","first-page":"774","article-title":"Is it time to perform only MRI targeted biopsy? Our experience in 1032 men submitted to prostate biopsy","volume":"200","author":"Pepe","year":"2018","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib8","article-title":"Transperineal prostate biopsy with cognitive magnetic resonance imaging\/biplanar ultrasound fusion: description of technique and early results","author":"Gorin","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1590\/s1677-5538.ibju.2018.0768","article-title":"Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions","volume":"45","author":"Westphalen","year":"2019","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41391-018-0065-6","article-title":"Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications","volume":"21","author":"Sathianathen","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.clgc.2020.04.001_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.21873\/anticanres.11333","article-title":"Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights","volume":"37","author":"Fandella","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clgc.2020.04.001_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2013.03.030","article-title":"Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: recommendations from an International Working Group","volume":"64","author":"Moore","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib13","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.clgc.2016.07.007","article-title":"Transperineal versus transrectal MRI\/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer","volume":"15","author":"Pepe","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2020.04.001_bib14","first-page":"248","article-title":"Biopsy of the anterior prostate gland: technique with end-fire transrectal ultrasound","volume":"82","author":"Galosi","year":"2010","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.clgc.2020.04.001_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.urology.2019.11.016","article-title":"How many cores should be obtained during saturation biopsy in the era of multiparametric magnetic resonance? Experience in 875 patients submitted to repeat prostate biopsy","volume":"137","author":"Pepe","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2020.04.001_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2020.04.001_bib17","first-page":"1403","article-title":"The prevalence of clinically significant prostate cancer according to commonly used histological thresholds in men undergoing template prostate mapping bopsies","volume":"195","author":"Valerio","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of survey","volume":"2","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.clgc.2020.04.001_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eururo.2017.08.018","article-title":"Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the prostate MR imaging study (PROMIS)","volume":"73","author":"Faria","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib20","first-page":"2395","article-title":"Cost-effectiveness of multiparametric MRI in 800 men submitted to repeat prostate biopsy: results of a public health model","volume":"38","author":"Pepe","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clgc.2020.04.001_bib21","first-page":"374","article-title":"The efficacy of multiparametric magnetic resonance imaging and magnetic resonance imaging targeted biopsy in risk classification for patients with prostate cancer on active surveillance","volume":"196","author":"Recabal","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clgc.2019.09.018","article-title":"Utility of multiparametric magnetic resonance imaging with PI-RADS, Version 2, in patients with prostate cancer eligible for active surveillance: which radiologic characteristics can predict unfavorable disease?","volume":"18","author":"Kim","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2020.04.001_bib23","first-page":"976","article-title":"Risk of upgrading from prostate biopsy to radical prostatectomy pathology: does saturation biopsy of index lesion during mpMRI-TRUS fusion biopsy help?","volume":"199","author":"Calio","year":"2018","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2020.02.006","article-title":"Combination of multiparametric magnetic resonance imaging with elastic-fusion biopsy has a high sensitivity in detecting clinically significant prostate cancer in daily practice","author":"Cecchini","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2020.04.001_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00345-016-1967-3","article-title":"Precision of MRI\/ultrasound-fusion biopsy in prostate cancer diagnosis: an ex\u00a0vivo comparison of alternative biopsy techniques on prostate phantoms","volume":"35","author":"Westhoff","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2020.04.001_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2214\/AJR.17.18680","article-title":"MRI-ultrasound fusion targeted biopsy of Prostate Imaging Reporting and Data System version 2 category 5 lesions found false-positive at multiparametric prostate MRI","volume":"210","author":"Sheridan","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clgc.2020.04.001_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.urology.2019.08.035","article-title":"Systematic biopsy does not contribute to disease upgrading in patients undergoing targeted biopsy for PI-RADS 5 lesions identified on magnetic resonance imaging in the course of active surveillance for prostate cancer","volume":"134","author":"Arabi","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2020.04.001_bib28","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s00261-017-1080-0","article-title":"Clinical and multiparametric MRI signatures of granulomatous prostatitis","volume":"42","author":"Rais-Bahrami","year":"2017","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.clgc.2020.04.001_bib29","article-title":"Prostate MR: pitfalls and benign lesions","author":"Chatterjee","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.clgc.2020.04.001_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.humpath.2018.08.021","article-title":"Histologic findings associated with false-positive multiparametric magnetic resonance imaging performed for prostate cancer detection","volume":"83","author":"Gordetsky","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clgc.2020.04.001_bib31","first-page":"59","article-title":"Clinical evaluation of the iXip index to reduce prostate re-biopsies","volume":"16","author":"Galosi","year":"2018","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.clgc.2020.04.001_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/bju.15048","article-title":"A\u00a0novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings","author":"Luzzago","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2020.04.001_bib33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3348\/kjr.2015.16.2.342","article-title":"Multiphase contrast-enhanced magnetic resonance imaging features of Bacillus Calmette-Gu\u00e9rin-induced granulomatous prostatitis in five patients","volume":"16","author":"Kawada","year":"2015","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.clgc.2020.04.001_bib34","article-title":"Performing precise biopsy in na\u00efve patients with equivocal PI-RADs v2 category 3 lesions: an MRI-based nomogram to avoid unnecessary surgical intervention","author":"Zhang","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2020.04.001_bib35","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.clgc.2014.06.013","article-title":"Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA\u00a0< 10 ng\/mL?","volume":"13","author":"Pepe","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2020.04.001_bib36","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00261-017-1081-z","article-title":"Multi-parametric MRI findings of granulomatous prostatitis developing after intravesical bacillus calmette-gu\u00e9rin therapy","volume":"42","author":"Gottlieb","year":"2017","journal-title":"Abdom Radiol (NY)"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767320300938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767320300938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:32:38Z","timestamp":1761564758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767320300938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1558767320300938"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2020.04.001","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Negative Biopsy Histology in Men With PI-RADS Score 5 in Daily Clinical Practice: Incidence of Granulomatous Prostatitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}